Oracle Stock Price Prediction: Will ORCL Hit $300 in 2026?
Any honest Oracle stock price prediction has to start with the tension at the center of the stock: Oracle is winning enormous AI cloud contracts, and it is spending almost as fast as it is booking them. After the company reported fiscal Q4 2026 results on June 10, ORCL slid from roughly $201 to around $192 even as revenue and backlog hit records. That gap — record bookings, falling stock — is the whole story.

So here is the direct answer. Wall Street's 12-month view is bullish, with an average target in the mid-$250s and the most aggressive analysts now at $300. Hitting that level is plausible but not automatic: it depends on Oracle converting a historic backlog into delivered, profitable cloud revenue without its ballooning capital spending swallowing the upside. Below is why the number could work, and where it could break.
Why this matters now: Oracle has repositioned itself from a legacy database vendor into one of the few credible "AI infrastructure landlords." That re-rating is most of the move in the stock over the past two years. The Q4 print is the first real test of whether the backlog is revenue or just a promise.
The quick answer: where ORCL stands now
As of June 10, 2026, ORCL traded around $192, off an intraday high near $212 and down from about $201 the prior session. The pullback came despite a record quarter — a classic "sell the news" reaction complicated by Oracle's plan to raise fresh capital. The consensus analyst rating remains Buy across roughly 35 covering analysts.
| Metric | Value (as of June 10, 2026) |
|---|---|
| Share price | ~$192 |
| Consensus rating | Buy (~35 analysts) |
| Avg 12-month target | ~$255 |
| High-end target | $300 |
| Low-end algo forecast | ~$180s |
| FY2027 revenue guide | $90B |
| FY2027 non-GAAP EPS guide | $8.05 (+18%) |
What just happened: Q4 FY2026 in numbers
The quarter was genuinely strong on the top line. The market's hesitation was about cost, not demand.
| Q4 FY2026 metric | Result | Change (YoY) |
|---|---|---|
| Total revenue | $19.2B | +21% |
| Total cloud revenue | $9.9B | +47% |
| Cloud infrastructure (OCI) | $5.8B | +93% |
| Cloud applications | $4.1B | +10% |
| EPS (GAAP) | $1.45 | +21% |
| EPS (non-GAAP) | $2.11 | +24% |
| Remaining Performance Obligations (RPO) | $638B | +$85B in the quarter |
| Capital expenditures | $55.7B (FY) | +162% |
The headline is the $638 billion RPO backlog, up from $553 billion, driven by large-scale AI contracts. But read the footnote: Oracle disclosed that about $75 billion of the increase was tied to deals where customers prepaid for GPUs or supplied the hardware themselves. That inflates the backlog optically and tells you these are capital-heavy, lower-margin arrangements, not classic high-margin software.
To fund the buildout, Oracle said it plans to raise about $40 billion in FY2027 through debt and equity, including a roughly $20 billion share sale. New shares dilute existing holders, and that is a large part of why the stock fell on otherwise record numbers.
Oracle stock price prediction: analyst targets and scenarios
Analyst models and algorithmic forecasts tell different stories, and the better reading is to weight them differently. Sell-side targets are anchored to earnings and guidance; multi-year algorithmic forecasts are trend extrapolations and deserve far more skepticism.
| Scenario | 12-month view | Rough price zone | What has to be true |
|---|---|---|---|
| Bull | Backlog converts fast, OCI margins hold | $290–$300+ | AI revenue lands on schedule, dilution is absorbed |
| Base | Steady cloud growth, heavy spend | $250–$270 | FY27 guidance ($90B rev) is met, margins stable |
| Bear | Capex outruns revenue, margin squeeze | $150–$185 | Delivery slips or financing costs bite |
Recent target revisions cluster bullish: Bank of America moved to $240, Oppenheimer to $275, and TD Cowen to $300, all maintaining Buy/Outperform. Longer-horizon third-party forecasts for 2027–2030 scatter widely — from the low $180s to $600-plus — which mostly tells you that multi-year point forecasts on a stock this capital-intensive are guesses dressed as precision. Treat any single 2030 number as a storyline, not a price.
The bull case — and the bill that comes with it
The bull case is simple and real: Oracle has become a preferred home for AI training and inference workloads, OCI is compounding near triple digits, and a $638 billion backlog gives multi-year revenue visibility most software firms can only envy. If even a clean majority of that converts at decent margins, $300 is reachable and FY2027's $90 billion revenue target looks conservative.
The more important point bulls gloss over is the bill. Capex up 162% to $55.7 billion, plus $40 billion of new financing, means Oracle is borrowing and issuing stock to build data centers for revenue it has not yet delivered. That is a leveraged bet on execution. It can work spectacularly — or it can compress free cash flow and the multiple at the same time if delivery slips.
The bear case most forecasts underweight
Three risks rarely make it into the cheerful year-by-year tables:
- Margin mix. GPU-prepaid and customer-supplied-hardware deals are not 80%-margin software. A backlog that swells on low-margin infrastructure is worth less per dollar than the headline implies.
- Dilution and debt. A ~$20 billion share sale and heavy borrowing arrive while interest costs are non-trivial. Every new share is a claim on the same earnings.
- Customer concentration and timing. A handful of very large AI customers drive the backlog. Delays, renegotiations, or a single pullback would hit both revenue and sentiment hard.
What experienced traders actually watch
Seasoned operators don't trade the press release; they trade the follow-through. Around an ORCL print, the traps are familiar: chasing the post-earnings spike before the dilution math sinks in, and treating RPO as if it were cash in the bank. The cleaner tells in coming quarters are OCI revenue actually delivered (not just booked), the gross-margin trend as hardware-heavy deals ramp, and free cash flow against that $55.7 billion capex line. If you also trade digital assets, you can watch how AI-infrastructure sentiment moves across both equities and crypto on a single markets dashboard, since the same AI narrative drives risk appetite in both.
Market view: The most useful framing is that ORCL is no longer priced as a software stock — it is priced as an AI-infrastructure buildout. That means the stock will likely trade on delivery and cash flow, not bookings. The $300 target is achievable, but the path runs through execution, not enthusiasm.
FAQ
1. What is the Oracle stock price prediction for 2026? Analyst 12-month targets center in the mid-$250s, with a bullish high near $300 and a more cautious low in the $150s–$180s. The range is wide because it hinges on how quickly Oracle's AI cloud backlog converts to delivered, profitable revenue against very heavy capital spending.
2. Why did ORCL stock fall after record Q4 FY2026 earnings? Revenue, cloud growth, and the $638B backlog all hit records, but Oracle also announced plans to raise about $40B (including a ~$20B share sale) and reported capex up 162%. Dilution and spending concerns outweighed the strong top line, pushing shares from about $201 to near $192.
3. Can Oracle stock reach $300? Yes, it's within the most bullish analyst targets. It would require Oracle to convert its AI backlog on schedule and at healthy margins while absorbing new share issuance. It is a realistic bull case, not a base case.
4. What is Oracle's RPO backlog and why does it matter? Remaining Performance Obligations are contracted revenue not yet recognized. Oracle's RPO jumped to $638B, signaling multi-year demand. The caveat: roughly $75B of the recent increase came from GPU-prepaid or customer-supplied-hardware deals, which are lower-margin than traditional software.
5. Is Oracle stock a buy right now? The consensus rating is Buy, but "consensus" is not a guarantee. The decision depends on your view of execution risk, tolerance for capex-driven volatility, and time horizon. This article is information, not investment advice — do your own research.
Risk Warning
Equities such as Oracle (ORCL) and crypto assets are volatile and can result in partial or total loss of capital. This article is for information only and is not investment advice, a recommendation, or a price guarantee. Oracle's outlook carries specific risks: heavy capital expenditure, new debt and equity issuance (dilution), customer concentration in large AI contracts, margin pressure from hardware-heavy deals, and broad macro or interest-rate shifts. Forecasts and analyst targets are estimates that frequently prove wrong. If you trade with leverage — in equities, futures, or crypto — losses can exceed your initial margin. Never invest more than you can afford to lose, size positions deliberately, and consider a licensed financial professional before acting.
You may also like

Best Time to Buy SpaceX IPO: $135 Price vs Post-Listing Strategy Explained
This guide breaks down how to think about buying the SpaceX IPO at the talked-about $135 price versus…

Where and How to Buy SpaceX IPO in 2026? Retail Investors Guide
SpaceX is set to capture global attention with its 2026 IPO, and retail investors want to know where…

Win Up to $60,000 Trading Rewards in Serenity Week on WEEX
WEEX is running Serenity Week with a total prize pool of $60,000 across spot and futures activities. This…

United States Water Reserve (USWR): Hype vs. Reality
United States Water Reserve (USWR) is a Solana meme coin, not tokenized water. See its tokenomics, whether it's legit, and the real risks before buying.

SPCX Price Prediction 2026–2030: One Ticker, Two Very Different Bets
SPCX price prediction for 2026–2030. The ticker means two assets — the Paimon SpaceX SPV token (~$220) and the $135 SpaceX IPO stock. Scenarios and risks.

What Is Project Oasis Coin (PXR)? A 2026 Guide to Price, Risks, and How to Buy
Project Oasis Coin (PXR) is a small-cap Solana token with an energy-reserve narrative but no documented team or backing. See the 2026 price, risks, and how to buy.

If You Can’t Buy SpaceX IPO, Is Rocket Lab the Next Best Thing?
Can’t get exposure to SpaceX because it’s still private? This piece compares SpaceX’s dominant, vertically integrated model with…

What Is the SpaceX IPO Price Prediction for 2026? Will Shares Be Worth Over $200?
SpaceX is expected to price its 2026 IPO around a $135 per-share anchor, with most forecasts pointing to…

SpaceX IPO vs Rocket Lab: The Billion-Dollar Space Race for Investors
SpaceX sits on the cusp of a potential IPO while Rocket Lab is already a liquid public proxy.…

SpaceX IPO vs Rocket Lab: Who Will Win the Space Investment Boom?
SpaceX is set to go public this week, while Rocket Lab stands out as the government’s “backup” launch…

What Is a Maker and Taker in Crypto Trading?
If you have ever placed a crypto trade and noticed the fee looked different from last time, you have already bumped into the maker-taker model. This guide explains what makers and takers actually are, how the fee structure works, and why it matters more than most beginners expect.

What Is Slippage in Crypto? A Beginner’s Guide
What exactly is slippage, why does it happen, and should traders worry about it? In this guide, we’ll explain what slippage in crypto means, why it happens, the difference between positive and negative slippage, and how traders can reduce its impact when buying or selling digital assets.

What Is USDC? A Beginner’s Guide to USD Coin
USDC is designed to maintain a stable value close to one U.S. dollar. This makes it popular among traders, investors, and everyday crypto users who want to reduce volatility without leaving the digital asset ecosystem.

USDT vs USDC: What’s the Difference and Which Stablecoin Is Better?
If you have spent any time in crypto, chances are you have come across two of the most widely used stablecoins in the market: USDT (Tether) and USDC (USD Coin). In this guide, we’ll break down the real differences between USDT and USDC, explain why traders often choose one over the other, and help you understand which stablecoin may make more sense for your needs.

What Is the Argentina FC Fan Token (ARG)? A 2026 Guide for Fans and Traders
Argentina FC is the Argentine FA Fan Token (ARG). Learn what it is, what holders get, how its price moves around the World Cup, and whether it's worth buying.

Claude Fable 5: What Anthropic's New AI Means for Crypto
Claude Fable 5 is Anthropic's most powerful public AI, launched June 9 2026. Here's how it differs from Mythos 5 and what it means for crypto.

What Is Strategic Bitcoin Reserve (SBR)? Token, Risks, and How to Buy
Strategic Bitcoin Reserve (SBR) is an Ethereum meme token, not a government reserve. See the verified contract, what drives the price, risks, and how to buy.

SpaceX IPO Prediction 2026: Date, $135 Price, $1.75 Trillion Valuation, and What SPCX Could Do Next
SpaceX IPO prediction for 2026: June 12 Nasdaq debut, $135 SPCX price, ~$1.75T valuation, bull/bear scenarios, and how to trade the theme on WEEX.
Best Time to Buy SpaceX IPO: $135 Price vs Post-Listing Strategy Explained
This guide breaks down how to think about buying the SpaceX IPO at the talked-about $135 price versus…
Where and How to Buy SpaceX IPO in 2026? Retail Investors Guide
SpaceX is set to capture global attention with its 2026 IPO, and retail investors want to know where…
Win Up to $60,000 Trading Rewards in Serenity Week on WEEX
WEEX is running Serenity Week with a total prize pool of $60,000 across spot and futures activities. This…
United States Water Reserve (USWR): Hype vs. Reality
United States Water Reserve (USWR) is a Solana meme coin, not tokenized water. See its tokenomics, whether it's legit, and the real risks before buying.
SPCX Price Prediction 2026–2030: One Ticker, Two Very Different Bets
SPCX price prediction for 2026–2030. The ticker means two assets — the Paimon SpaceX SPV token (~$220) and the $135 SpaceX IPO stock. Scenarios and risks.
What Is Project Oasis Coin (PXR)? A 2026 Guide to Price, Risks, and How to Buy
Project Oasis Coin (PXR) is a small-cap Solana token with an energy-reserve narrative but no documented team or backing. See the 2026 price, risks, and how to buy.




